“Explore the significance of patient-centric approaches in clinical trials. Discover the benefits, challenges, and how Boston-based consulting firms are driving this essential shift in research.”
Patient-centric frameworks involve patients in the research process focusing on their needs, choices and experiences. But the shock factor is definitely out thereand that is far less than 20% of clinical trials use these patient-centric approaches today. The article dives deeper into patient-centric strategies, the roadblocks to their adoption and why cBioBoston play a major role in driving them.
The Importance of Patient-Centric Methods in Clinical Research
With some human-centered trials, the research design may increase participation from patients and involve them throughout the life cycle of a study. Such methods can hopefully enhance patient recruitment, retention and satisfaction underpinning more robust and generalizable research outputs.
Patients are at the core of any patient-centric approach
Patient Engagement — Meaning using and involving Patients directly in the designing of such clinical trials.
The Voice of the Patient: Working with advocacy groups to make sure patients have a say.
Personalized Medicine: Treatments are specific to each patient and their genetic constitution.
Patient Education: Communication of the study and its implications in a digestible way.
Informed Consent: the process whereby subjects agree to participate after they are fully informed about the study requirements.
Feedback enabling processes, mechanisms for incorporating patient feedback to refine research iteratively
Digital Health: This involves using digital tools and platforms for collecting patient data, monitoring patients, etc.
Telemedicine: Providing virtual consultations and follow-ups to increase accessibility.
Unbiased Trials: Running trials across a wide array of real-world settings instead of the typical research center.
RWE — Data from daily patient experience to drive research.
Quality of Life Metrics: Patient-reported outcomes (PRO) are used to assess the quality of life impacts and those metrics must be used to derive utility in a cost-effectiveness analysis.
Open and Transparent Dissemination of Findings to Study Participants
Ethical Concerns: Adherence to the most rigorous ethical principles in order to safeguard the well-being of patients.
Regulatory Compliance: Making sure that all patient-centric activity is compliant with regulatory standards.
Interdisciplinary Collaboration: Collaborating with a diverse group of healthcare professionals in order to meet patient care needs.
Extracting Data: Reviews summarized the trials based on standard data elements (study design, population studied, how patients were recruited) but also adherence to patient-centered design principles of structuring study protocols around the convenience and comfort of participants.
Flexible: Patients could schedule study visits at their own time.
House Calls: Allowing select study functions to be conducted at the patient’s place of residence
Cultural Sensitivity Cultural sensitivity: creating study materials and communication tailored for diverse cultures.
Follow-up: Contacting patients with a follow up even after the study is completed to observe longer term effects.
Challenges to Adoption of Patient-Centric Approaches
While the advantages are evident, a number of barriers stand in the way for patient-centered approaches to be more broadly utilized in clinical research.
Expense: Some patient-centric methods may be more expensive to implement than traditional approaches.
This is because it is really complex to design and run trials that are truly patient-centric.
Regulatory Hurdles: Compliance with the regulatory aspects of handling brand new approaches is also a challenge.
Refusal to Change: Some researchers and institutions might refuse to adopt new techniques.
Data Management: Managing a higher volume and variety of data from patient-centric trials can be complicated.
The Role of Consulting Firms in Promoting Patient-Centric Research
With Boston as an epicenter of Biotech, Pharma and Life Science, there are many consulting firms that specialize in the space. These companies are an integral component that drives patient-centered clinical research efforts.
Conclusion: The Future of Clinical Trials
Although fewer than 20% of clinical trials today use patient-centric methods, the benefits of this approach are well-documented. Clinical Trials could get better recruitment, retention, as well as outcomes if patients were prioritized in conducting the study. Firms that do offer support for overcoming these challenges can be found across the globe at the leading edge of this movement and in Boston, local consulting firms are playing a key role in ushering in a new era of patient-centric practices. The industry will rely heavily on these methodologies going forth as it continues to transform and push medical research and patient care ahead.
Get in touch with BioBoston Consulting or check us out online for more information on how we can help your organization.
